The following is a summary of “Effect of the EXOPULSE Mollii Suit on pain and fibromyalgia-related symptoms—A randomized sham ...

Post-treatment Lyme disease syndrome (PTLDS) is a condition in which symptoms persist 6 months after the patient has received ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

Turkey: A recent cross-sectional study has revealed promising results for patients suffering from both fibromyalgia and ...

Below is the list of 87 musculoskeletal conditions being supported through PIP to help with either daily living, mobility ...

Remedee Labs, a French start-up that specializes in non-pharmacological treatments for chronic pain, is announcing today that ...

A successful claim for PIP is worth between £28.70 and £184.30 each week in additional financial support and, as the benefit ...

Higher doses of commonly prescribed ADHD medications may increase the risk of psychosis, a new study has found Getty High doses of commonly prescribed medications for ADHD have been linked to an ...

Different medical conditions, aging, and lifestyle habits can all contribute to these symptoms. When nondrug strategies fail to help, medications are available to address symptoms and improve quality ...

Solriamfetol hydrochloride is under clinical development by Axsome Therapeutics and currently in Phase II for Fatigue.

Groundbreaking Study Confirms Fibromyalgia as a True Medical Condition with 100% Accuracy Using Unique DNA Genomic Signatures, Offering New Hope for Objective Diagnosis and Treatment.​ LOS ANGELES, CA ...